Splice variants of the nuclear dot-associated Sp100 protein contain homologies to HMG-1 and a human nuclear phosphoprotein-box motif

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Guldner, H. H.
	Articles by Sternsdorf, T.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Guldner, H. H.
	Articles by Sternsdorf, T.

Alcalay, M., Tomassoni, L., Colombo, E., Stoldt, S., Grignani, F., Fagioli, M., Szekely, L., Helin, K. and Pelicci, P. G (1998). The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol. Cell Biol 18, 1084-1093.[Abstract/Free Full Text]

Ascoli, C. A. and Maul, G. G (1991). Identification of a novel nuclear domain. J. Cell Biol 112, 785-795.[Abstract/Free Full Text]

Baxevanis, A. D. and Landsman, D (1995). The HMG-1 box protein family: classification and functional relationships. Nucl. Acids Res 23, 1604-1613.[Abstract/Free Full Text]

Bloch, D. B., de la Monte, S. M., Guigaouri, P., Filippov, A. and Bloch, K. D (1996). Identification and characterization of a leukocyte-specific component of the nuclear body. J. Biol. Chem 271, 29198-29204.[Abstract/Free Full Text]

Boddy, M. N., Howe, K., Etkin, L. D., Solomon, E. and Freemont, P. S (1996). PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene 13, 971-982.[Medline]

Boshart, M., Weber, F., Jahn, G., Dorsch, H. K., Fleckenstein, B. and Schaffner, W (1985). A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41, 521-530.[Medline]

Brasch, K. and Ochs, R. L (1992). Nuclear bodies (NBs): A newly \324rediscovered' organelle. Exp. Cell Res 202, 211-223.[Medline]

Bustin, M., Lehn, D. A. and Landsman, D (1990). Structural features of the HMG chromosomal proteins and their genes. Biochim. Biophys. Acta 1049, 231-243.[Medline]

Buwitt, U., Flohr, T. and Bottger, E. C (1992). Molecular cloning and characterization of an interferon induced human cDNA with sequence homology to a mammalian peptide chain release factor. EMBO J 11, 489-496.[Medline]

Cao, T., Duprez, E., Borden, K. L., Freemont, P. S. and Etkin, L. D (1998). Ret finger protein is a normal component of PML nuclear bodies and interacts directly with PML. J. Cell Sci 111, 1319-1329.[Abstract]

Carvalho, T., Seeler, J. S., \205hman, K., Jordan, P., Pettersson, U., Akusj\212rvi, G., Carmo-Fonseca, M. and Dejean, A (1995). Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J. Cell Biol 131, 45-56.[Abstract/Free Full Text]

Chan, J. Y., Li, L., Fan, Y. H., Mu, Z. M., Zhang, W. W. and Chang, K. S (1997). Cell-cycle regulation of DNA damage-induced expression ofthe suppressor gene PML. Biochem. Biophys. Res. Commun 240, 640-646.[Medline]

Chelbi-Alix, M. K., Pelicano, L., Quignon, F., Koken, M. H. M., Venturini, L., Stadler, M., Pavlovic, J., Degos, L. and de The, H (1995). Inductionof the PML protein by interferons in normal and APL cells. Leukemia 9, 2027-2033.[Medline]

Chelbi-Alix, M. K., Quignon, F., Pelicano, L., Koken, M. H. and de The, H (1998). Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J. Virol 72, 1043-1051.[Abstract/Free Full Text]

Dang, C. V. and Lee, W. M (1989). Nuclear and nucleolar targeting sequences of c-erb-A, c-myb, N-myc, p53, HSP70, and HIV tat proteins. J. Biol. Chem 264, 18019-18023.[Abstract/Free Full Text]

Daniel, M. T., Koken, M. H. M., Romagne, O., Barbey, S., Bazarbachi, A., Stadler, M., Guillemin, M. C., Degos, L., Chomienne, C. and de The, H (1993). PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood 82, 1858-1867.[Abstract/Free Full Text]

de The, H., Riviere, M. and Bernhard, W (1960). Examen au microscope electronique de la tumeur VX2 du lapin domestique derivee du papillome de shope. Bull. Cancer 47, 569-584.

de The, H., Chomienne, C., Lanotte, M., Degos, L. and Dejean, A (1990). The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347, 558-561.[Medline]

Dent, A. L., Yewdell, J., Puviondutilleul, F., Koken, M. H. M., de The, H. and Staudt, L. M (1996). LYSP100-associated nuclear domains (LANDs): Description of a new class of subnuclear structures and their relationship to PML nuclear bodies. Blood 88, 1423-1436.[Abstract/Free Full Text]

Dingwall, C. and Laskey, R. A (1991). Nuclear targeting sequences\321a consensus?. Trends Biochem. Sci 16, 478-481.[Medline]

Doucas, V. and Evans, R. M (1996). The PML nuclear compartment and cancer. Biochim. Biophys. Acta 1288, 25-.

Dyck, J. A., Maul, G. G., Miller, W. J., Chen, J. D., Kakizuka, A. and Evans, R. M (1994). A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76, 333-343.[Medline]

Fagioli, M., Alcalay, M., Pandolfi, P. P., Venturini, L., Mencarelli, A., Simeone, A., Acampora, D., Grignani, F. and Pelicci, P. G (1992). Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene 7, 1083-1091.[Medline]

Gariglio, M., Ying, G. G., Hertel, L., Gaboli, M., Clerc, R. G. and Landolfo, S (1997). The high-mobility group protein T160 binds to both linear and cruciform DNA and mediates DNA bending as determined by ring closure. Exp. Cell Res 236, 472-481.[Medline]

Giese, K., Cox, J. and Grosschedl, R (1992). The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69, 185-195.[Medline]

Goddard, A. D., Borrow, J., Freemont, P. S. and Solomon, E (1991). Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254, 1371-1374.[Abstract/Free Full Text]

Gongora, C., David, G., Pintard, L., Tissot, C., Hua, T. D., Dejean, A. and Mechti, N (1997). Molecular cloning of a new interferon-induced PML nuclear body-associated protein. J. Biol. Chem 272, 19457-19463.[Abstract/Free Full Text]

Grande, M. A., van der Kraan, I., van Steensel, B., Schul, W., de The, H., van der Voort, H. T., de Jong, L. and van Driel, R (1996). PML-containing nuclear bodies: their spatial distribution in relation to other nuclear components. J. Cell Biochem 63, 280-291.[Medline]

Gross, C. T. and McGinnis, W (1996). DEAF-1, a novel protein that binds an essential region in a Deformed response element. EMBO J 15, 1961-1970.[Medline]

Grosschedl, R. K., Giese, K. and Pagel, J (1994). HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet 10, 94-100.[Medline]

Gr\232tzinger, T., Jensen, K., Guldner, H. H., Sternsdorf, T., Szostecki, C., Schwab, M., Savelyeva, L., Reich, B. and Will, H (1996). A highly amplified mouse gene is homologous to the human interferon-responsive Sp100 gene encoding an autoantigen associated with nuclear dots. Mol. Cell Biol 16, 1150-1156.[Abstract]

Gr\232tzinger, T., Jensen, K. and Will, H (1996). The interferon (IFN)-stimulated gene Sp100 promoter contains an IFN gamma activation site and an imperfect IFN-stimulated response element which mediate type I IFN inducibility. J. Biol. Chem 271, 25253-25260.[Abstract/Free Full Text]

Gr\232tzinger, T., Sternsdorf, T., Jensen, K. and Will, H (1996). Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). Eur. J. Biochem 238, 554-560.[Medline]

Guldner, H. H., Lakomek, H. J. and Bautz, F. A (1986). Anti-(U1)RNP and anti-Sm autoantibody profiles in patients with systemic rheumatic diseases: differential detection of immunoglobulin G and M by immunoblotting. Clin. Immunol. Immunopathol 40, 532-538.[Medline]

Guldner, H. H., Netter, H. J., Szostecki, C., Jaeger, E. and Will, H (1990). Human anti-p68 autoantibodies recognize a common epitope of U1 RNA containing small nuclear ribonucleoprotein and influenza B virus. J. Exp. Med 171, 819-829.[Abstract/Free Full Text]

Guldner, H. H., Szostecki, C., Gr\232tzinger, T. and Will, H (1992). IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. J. Immunol 149, 4067-4073.[Abstract]

Hartl, P. and Lipp, M (1987). Generation of a variant t(2;8) translocation of Burkitt's lymphoma by site-specific recombination via the kappa light-chain joining signals. Mol. Cell Biol 7, 2037-2045.[Abstract/Free Full Text]

Jantzen, H. M., Admon, A., Bell, S. P. and Tjian, R (1990). Nucleolar transcription factor hUBF contains a DNA-binding motif with homology to HMG proteins. Nature 344, 830-836.[Medline]

Kadereit, S., Gewert, D. R., Galabru, J., Hovanessian, A. G. and Meurs, E. F (1993). Molecular cloning of two new interferon-induced, highly related nuclear phosphoproteins. J. Biol. Chem 268, 24432-24441.[Abstract/Free Full Text]

Kakizuka, A., Miller, W. J., Umesono, K., Warrell, R. J., Frankel, S. R., Murty, V. V., Dmitrovsky, E. and Evans, R. M (1991). Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66, 663-674.[Medline]

Kamei, H (1997). Cystine starvation induces reversible large-body formation from nuclear bodies in T24 cells. Exp. Cell Res 237, 207-216.[Medline]

Kamitani, T., Kito, K., Nguyen, H. P., Wada, H., Fukuda-Kamitani, T. and Yeh, E. T. H (1998). Identification of three major sentrinization sites in PML. J. Biol. Chem 273, 26675-26682.[Abstract/Free Full Text]

Koken, M. H., Reid, A., Quignon, F., Chelbi-Alix, M. K., Davies, J. M., Kabarowski, J. H., Zhu, J., Dong, S., Chen, S., Chen, Z. et al (1997). Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. Proc. Nat. Acad. Sci. USA 94, 10255-10260.[Abstract/Free Full Text]

Koken, M. H. M., Linares-Cruz, G., Quignon, F., Viron, A., Chelbi-Alix, M. K., Sobczak-Thepot, J., Juhlin, L., Degos, L., Calvo, F. and de The, H (1995). The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10, 1315-1324.[Medline]

Koken, M. H. M., Puvion, D. F., Guillemin, M. C., Viron, A., Linares-Cruz, G., Stuurman, N., de Jong, L., Szostecki, C., Calvo, F., Chomienne, C. et al (1994). The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J 13, 1073-1083.[Medline]

Korioth, F., Gieffers, C., Maul, G. G. and Frey, J (1995). Molecular characterization of NDP52, a novel protein of the nuclear domain 10, which is redistributed upon virus infection and interferon treatment. J. Cell Biol 130, 1-13.[Abstract/Free Full Text]

Lamond, A. I. and Earnshaw, W. C (1998). Structure and function in the nucleus. Science 280, 547-553.[Abstract/Free Full Text]

LaMorte, V. J., Dyck, J. A., Ochs, R. L. and Evans, R. M (1998). Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc. Nat. Acad. Sci. USA 95, 4991-4996.[Abstract/Free Full Text]

Laudet, V., Stehelin, D. and Clevers, H (1993). Ancestry and diversity of the HMG box superfamily. Nucl. Acids Res 21, 2493-2501.[Abstract/Free Full Text]

Lavau, C., Marchio, A., Fagioli, M., Jansen, J., Falini, B., Lebon, P., Grosveld, F., Pandolfi, P. P., Pelicci, P. G. and Dejean, A (1995). The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene 11, 871-878.[Medline]

LeBoeuf, R. D., Ban, E. M. H., Green, M. M., Stone, A. S., Probst, S. M., Blalock, E. J. and Tauber, J. D (1998). Molecular cloning, sequence analysis, expression, and tissue distribution of Suppressin, a novel suppressor of cell cycle entry. J. Biol. Chem 273, 361-368.[Abstract/Free Full Text]

LeBoeuf, R. D., Burns, J. N., Bost, K. L. and Blalock, J. E (1990). Isolation, purification, and partial characterization of suppressin, a novel inhibitor of cell proliferation. J. Biol. Chem 265, 158-165.[Abstract/Free Full Text]

Lehming, N., Le Saux, A., Schuller, J. and Ptashne, M (1998). Chromatin components as part of a putative transcriptional repressing complex. Proc. Nat. Acad. Sci. USA 95, 7322-7326.[Abstract/Free Full Text]

Lovell-Badge, R (1995). Developmental genetics. Living with bad architecture. Nature 376, 725-726.[Medline]

Maul, G. G., Yu, E., Ishov, A. M. and Epstein, A. L (1995). Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stress. J. Cell Biochem 59, 498-513.[Medline]

Mu, Z. M., Chin, K. V., Liu, J. H., Lozano, G. and Chang, K. S (1994). PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell Biol 14, 6858-6867.[Abstract/Free Full Text]

Mu, Z. M., Le, X. F., Glassman, A. B. and Chang, K. S (1996). The biologic function of PML and its role in acute promyelocytic leukemia. Leuk. Lymphoma 23, 277-285.[Medline]

Muller, S., Matunis, M. J. and Dejean, A (1998). Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J 17, 61-70.[Medline]

Ohndorf, U. M., Whitehead, J. P., Raju, N. L. and Lippard, S. J (1997). Binding of tsHMG, a mouse testis-specific HMG-domain protein, to cisplatin-DNA adducts. Biochemistry 36, 14807-14815.[Medline]

Plass, C., Weichenhan, D., Kunze, B., Hellwig, T., Schneider, C., Bautz, F. A., Grzeschik, K. H., Traut, W. and Winking, H (1995). A member of the mouse LRR transcript family with homology to the human Sp100 gene. Hereditas 122, 245-256.[Medline]

P\232hler, J. R., Norman, D. G., Bramham, J., Bianchi, M. E. and Lilley, D. M (1998). HMG box proteins bind to four-way DNA junctions in their open conformation. EMBO J 17, 817-826.[Medline]

Quignon, F., De Bels, F., Koken, M., Feunteun, J., Ameisen, J. C. and de The, H (1998). PML induces a novel caspase-independent death process. Nat. Genet 20, 259-265.[Medline]

Reyes, J. C., Muchardt, C. and Yaniv, M (1997). Components of the human SWI/SNF complex are enriched in active chromatin and are associated with the nuclear matrix. J. Cell Biol 137, 263-274.[Abstract/Free Full Text]

Ross, J (1995). mRNA stability in mammalian cells. Microbiol. Rev 59, 423-450.[Abstract/Free Full Text]

Saitoh, H., Pu, R. T. and Dasso, M (1997). SUMO-1: wrestling with a new ubiquitin-related modifier. Trends Biochem. Sci 22, 374-376.[Medline]

Seeler, J. S., Marchio, A., Sitterlin, D., Transy, C. and Dejean, A (1998). Interaction of SP100 with HP1 proteins: A link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc. Nat. Acad. Sci. USA 95, 7316-7321.[Abstract/Free Full Text]

Shirakawa, H. and Yoshida, M (1992). Structure of a gene coding for human HMG2 protein. J. Biol. Chem 267, 6641-6645.[Abstract/Free Full Text]

Skinner, P. J., Koshy, B. T., Cummings, C. J., Klement, I. A., Helin, K., Servadio, A., Zoghbi, H. Y. and Orr, H. T (1997). Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 389, 971-974.[Medline]

Stadler, M., Chelbi-Alix, M. K., Koken, M. H. M., Venturini, L., Lee, C., Saib, A., Quignon, F., Pelicano, L., Guillemin, M. C., Schindler, C. and de The, H (1995). Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 11, 2565-2573.[Medline]

Stemler, M., Weimer, T., Tu, Z. X., Wan, D. F., Levrero, M., Jung, C., Pape, G. R. and Will, H (1990). Mapping of B-cell epitopes of the human hepatitis B virus X protein. J. Virol 64, 2802-2809.[Abstract/Free Full Text]

Sternsdorf, T., Gr\232tzinger, T., Jensen, K. and Will, H (1997). Nuclear dots: Actors on many stages. Immunobiology 198, 307-331.[Medline]

Sternsdorf, T., Jensen, K. and Will, H (1997). Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J. Cell Biol 139, 1621-1634.[Abstract/Free Full Text]

Sternsdorf, T., Jensen, K., Zuchner, D. and Will, H (1997). Cellularlocalization, expression, and structure of the nuclear dot protein 52. J. Cell Biol 138, 435-448.[Abstract/Free Full Text]

Stros, M. and Dixon, G. H (1993). A retropseudogene for non-histone chromosomal protein HMG-1. Biochim. Biophys. Acta 1172, 231-235.[Medline]

Szostecki, C., Krippner, H., Penner, E. and Bautz, F. A (1987). Autoimmune sera recognize a 100 kD nuclear protein antigen (Sp100). Clin. Exp. Immunol 68, 108-116.[Medline]

Szostecki, C., Guldner, H. H., Netter, H. J. and Will, H (1990). Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J. Immunol 145, 4338-4347.[Abstract]

Szostecki, C., Will, H., Netter, H. J. and Guldner, H. H (1992). Autoantibodies to the nuclear Sp100 protein in primary biliary cirrhosis and associated diseases: epitope specificity and immunoglobulin class distribution. Scand. J. Immunol 36, 555-564.[Medline]

Terris, B., Baldin, V., Dubois, S., Degott, C., Flejou, J. F., Henin, D. and Dejean, A (1995). PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res 55, 1590-1597.[Abstract/Free Full Text]

Tjian, R. and Maniatis, T (1994). Transcriptional activation: a complex puzzle with few easy pieces. Cell 77, 5-8.[Medline]

Vallian, S., Gaken, J. A., Trayner, I. D., Gingold, E. B., Kouzarides, T., Chang, K. S. and Farzaneh, F (1997). Transcriptional repression by the promyelocytic leukemia protein, PML. Exp. Cell Res 237, 371-382.[Medline]

Wang, J. F., Bashir, M., Engelsberg, B. N., Witmer, C., Rozmiarek, H. and Billings, P. C (1997). High mobility group proteins 1 and 2 recognize chromium-damaged DNA. Carcinogenesis 18, 371-375.[Abstract/Free Full Text]

Wang, W., Chi, T., Xue, Y., Zhou, S., Kuo, A. and Crabtree, G. R (1998). Architectural DNA binding by a high-mobility-group/kinesin-like subunit in mammalian SWI/SNF-related complexes. Proc. Nat. Acad. Sci. USA 95, 492-498.[Abstract/Free Full Text]

Wang, Z. G., Ruggero, D., Ronchetti, S., Zhong, S., Gaboli, M., Rivi, R. and Pandolfi, P. P (1998). PML is essential for multiple apoptotic pathways. Nat. Genet 20, 266-272.[Medline]

Weichenhan, D., Kunze, B., Zacker, S., Traut, W. and Winking, H (1997). Structure and expression of the murine Sp100 nuclear dot gene. Genomics 43, 298-306.[Medline]

Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A. and Dejean, A (1994). Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell 76, 345-356.[Medline]

Wen, L., Huang, J. K., Johnson, B. H. and Reeck, G. R (1989). A human placental cDNA clone that encodes nonhistone chromosomal protein HMG-1. Nucl. Acids Res 17, 1197-1214.[Abstract/Free Full Text]

Wolffe, A. P (1994). Architectural transcription factors. Science 264, 1100-1111.[Free Full Text]

Xie, K., Lambie, E. J. and Snyder, M (1993). Nuclear dot antigens may specify transcriptional domains in the nucleus. Mol. Cell Biol 13, 6170-6179.[Abstract/Free Full Text]

Zheng, P., Guo, Y., Niu, Q., Levy, D. E., Dyck, J. A., Lu, S., Sheiman, L. A. and Liu, Y (1998). Proto-oncogene PML controls genes devoted to MHC class I antigen presentation. Nature 396, 373-376.[Medline]

This article has been cited by other articles:

Y.-C. M. Chen, C. Kappel, J. Beaudouin, R. Eils, and D. L. Spector
Live Cell Dynamics of Promyelocytic Leukemia Nuclear Bodies upon Entry into and Exit from Mitosis
Mol. Biol. Cell, July 1, 2008; 19(7): 3147 - 3162.
[Abstract] [Full Text] [PDF]

R. D. Everett, C. Parada, P. Gripon, H. Sirma, and A. Orr
Replication of ICP0-Null Mutant Herpes Simplex Virus Type 1 Is Restricted by both PML and Sp100
J. Virol., March 15, 2008; 82(6): 2661 - 2672.
[Abstract] [Full Text] [PDF]

R. D. Everett, S. Rechter, P. Papior, N. Tavalai, T. Stamminger, and A. Orr
PML Contributes to a Cellular Mechanism of Repression of Herpes Simplex Virus Type 1 Infection That Is Inactivated by ICP0.
J. Virol., August 1, 2006; 80(16): 7995 - 8005.
[Abstract] [Full Text] [PDF]

C. Wasylyk, S. E. Schlumberger, P. Criqui-Filipe, and B. Wasylyk
Sp100 Interacts with ETS-1 and Stimulates Its Transcriptional Activity
Mol. Cell. Biol., April 15, 2002; 22(8): 2687 - 2702.
[Abstract] [Full Text] [PDF]

U. Manne, B. D. Gary, D. K. Oelschlager, H. L. Weiss, A. R. Frost, and W. E. Grizzle
Altered Subcellular Localization of Suppressin, a Novel Inhibitor of Cell-Cycle Entry, Is an Independent Prognostic Factor in Colorectal Adenocarcinomas
Clin. Cancer Res., November 1, 2001; 7(11): 3495 - 3503.
[Abstract] [Full Text] [PDF]

J.-S. Seeler, A. Marchio, R. Losson, J. M. P. Desterro, R. T. Hay, P. Chambon, and A. Dejean
Common Properties of Nuclear Body Protein SP100 and TIF1{alpha} Chromatin Factor: Role of SUMO Modification
Mol. Cell. Biol., May 15, 2001; 21(10): 3314 - 3324.
[Abstract] [Full Text]

D Negorev, A. Ishov, and G. Maul
Evidence for separate ND10-binding and homo-oligomerization domains of Sp100
J. Cell Sci., January 1, 2001; 114(1): 59 - 68.
[Abstract] [PDF]

S. Kaul, J. A. Blackford Jr., J. Chen, V. V. Ogryzko, and S. S. Simons Jr.
Properties of the Glucocorticoid Modulatory Element Binding Proteins GMEB-1 and -2: Potential New Modifiers of Glucocorticoid Receptor Transactivation and Members of the Family of KDWK Proteins
Mol. Endocrinol., July 1, 2000; 14(7): 1010 - 1027.
[Abstract] [Full Text]

J. Pitkanen, V. Doucas, T. Sternsdorf, T. Nakajima, S. Aratani, K. Jensen, H. Will, P. Vahamurto, J. Ollila, M. Vihinen, et al.
The Autoimmune Regulator Protein Has Transcriptional Transactivating Properties and Interacts with the Common Coactivator CREB-binding Protein
J. Biol. Chem., May 26, 2000; 275(22): 16802 - 16809.
[Abstract] [Full Text] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Guldner, H. H.

Articles by Sternsdorf, T.

Search for Related Content

PubMed

PubMed Citation

Articles by Guldner, H. H.

Articles by Sternsdorf, T.

				R. D. Everett, C. Parada, P. Gripon, H. Sirma, and A. Orr Replication of ICP0-Null Mutant Herpes Simplex Virus Type 1 Is Restricted by both PML and Sp100 J. Virol., March 15, 2008; 82(6): 2661 - 2672. [Abstract] [Full Text] [PDF]

				R. D. Everett, S. Rechter, P. Papior, N. Tavalai, T. Stamminger, and A. Orr PML Contributes to a Cellular Mechanism of Repression of Herpes Simplex Virus Type 1 Infection That Is Inactivated by ICP0. J. Virol., August 1, 2006; 80(16): 7995 - 8005. [Abstract] [Full Text] [PDF]

				C. Wasylyk, S. E. Schlumberger, P. Criqui-Filipe, and B. Wasylyk Sp100 Interacts with ETS-1 and Stimulates Its Transcriptional Activity Mol. Cell. Biol., April 15, 2002; 22(8): 2687 - 2702. [Abstract] [Full Text] [PDF]

				U. Manne, B. D. Gary, D. K. Oelschlager, H. L. Weiss, A. R. Frost, and W. E. Grizzle Altered Subcellular Localization of Suppressin, a Novel Inhibitor of Cell-Cycle Entry, Is an Independent Prognostic Factor in Colorectal Adenocarcinomas Clin. Cancer Res., November 1, 2001; 7(11): 3495 - 3503. [Abstract] [Full Text] [PDF]

				J.-S. Seeler, A. Marchio, R. Losson, J. M. P. Desterro, R. T. Hay, P. Chambon, and A. Dejean Common Properties of Nuclear Body Protein SP100 and TIF1{alpha} Chromatin Factor: Role of SUMO Modification Mol. Cell. Biol., May 15, 2001; 21(10): 3314 - 3324. [Abstract] [Full Text]

				D Negorev, A. Ishov, and G. Maul Evidence for separate ND10-binding and homo-oligomerization domains of Sp100 J. Cell Sci., January 1, 2001; 114(1): 59 - 68. [Abstract] [PDF]

				S. Kaul, J. A. Blackford Jr., J. Chen, V. V. Ogryzko, and S. S. Simons Jr. Properties of the Glucocorticoid Modulatory Element Binding Proteins GMEB-1 and -2: Potential New Modifiers of Glucocorticoid Receptor Transactivation and Members of the Family of KDWK Proteins Mol. Endocrinol., July 1, 2000; 14(7): 1010 - 1027. [Abstract] [Full Text]

				J. Pitkanen, V. Doucas, T. Sternsdorf, T. Nakajima, S. Aratani, K. Jensen, H. Will, P. Vahamurto, J. Ollila, M. Vihinen, et al. The Autoimmune Regulator Protein Has Transcriptional Transactivating Properties and Interacts with the Common Coactivator CREB-binding Protein J. Biol. Chem., May 26, 2000; 275(22): 16802 - 16809. [Abstract] [Full Text] [PDF]